25 Spam-Free Article(s) Found
||Assembly Biosciences, Inc.
Nov 08, 2018 - Assembly Biosciences (ASMB) delivered earnings and revenue surprises of 14.71% and 33.40%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Oct 31, 2018 - Assembly Biosciences (ASMB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 08, 2018 -
Assembly Biosciences Inc (NASDAQ: ASMB) shares have shed over one-fourth of their value since late September, creating an opportunity to buy the dip, B. Riley FBR said Monday.
Oct 08, 2018 - B. Riley FBR issues rating change for ASMB
Jul 11, 2018 - Assembly Biosciences (NASDAQ:ASMB) priced public offering of 4M common at $36/share for gross proceeds of $144M.Underwriters have a 30-day option to purchase up to an additional 0.6M common shares.Th
Jun 01, 2018 - It's been six months since I presented 4 hedged portfolios and 10 top names in week 27 of my Marketplace service (November 30th). Here's how everything did. This was the worst week yet. All 4 portfoli
May 07, 2018 - Assembly Biosciences (NASDAQ:ASMB): Q1 EPS of -$0.80 misses by $0.04.Revenue of $3.57M (+425.0% Y/Y) beats by $1.69M.Press Release
Apr 13, 2018 -
Assembly Biosciences Inc (NASDAQ: ASMB) made a poster presentation of interim results from two early-stage studies for its ABI-H073, a
|Apr 2018||Chardan Capital||Downgrades||Buy||Neutral |
|Jan 2018||B. Riley||Initiates Coverage On||Neutral |
|Nov 2017||Jefferies||Initiates Coverage On||Buy |
View More Analyst Ratings for ASMB
View the Latest Analyst Ratings
Apr 13, 2018 - Reata provided an update on the CARDINAL study of bardoxolone.Assembly Biosciences reports results for ABI-H0731.FDA lifts clinical hold on Bellicum’s BPX-501 studies.
Apr 13, 2018 - Chardan Capital Markets issues rating change for ASMB